INSMED Inc
For the period ended Dec 31, 2023. Filed Feb 22, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 22, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 9B. OTHER INFORMATION
Rule 10b5-1 Trading Plans
During the three months ended December 31, 2023, certain of our officers and directors adopted orterminated Rule 10b5-1 trading plans as follows:
Michael A. Smith, our Chief Legal Officer, entered into a prearranged stock trading arrangement (the Trading Plan) on December 14, 2023. Mr. Smith’s Trading Plan provides for the sale of an aggregate number of up to 44,722 shares of the Company's common stock between March 15, 2024 and September 16, 2024. The Trading Plan was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and the Company’s policies regarding insider transactions.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.